Table 1.
Covariate | NHS participants | Medicare controls (before matching) | Medicare controls (after matching) | Std. differencea(after matching) |
---|---|---|---|---|
N | 47,194 | 2,834,525 | 47,194 | |
Age as of January 1, 2012, mean (std) | 76.6 (6.8) | 76.1 (8.1) | 76.5 (7.5) | 0.02 |
Race, N (%) | ||||
White | 46,036 (97.6) | 2,457,989 (86.7) | 46,242 (98.0) | −0.03 |
Black | 696 (1.5) | 218,150 (7.7) | 588 (1.3) | 0.03 |
Other | 438 (0.9) | 111,084 (3.9) | 345 (0.7) | 0.02 |
Hispanic | 24 (0.1) | 47,302 (1.7) | 19 (0.0) | 0.01 |
Socioeconomic status | ||||
Dual eligible, N (%) | 1,187 (2.5) | 490,890 (17.3) | 948 (2.0) | 0.04 |
Median income,b mean (std) | $66,374 ($24,724) | $57,438 ($23,030) | $66,264 ($25,302) | 0.01 |
Census region, N (%) | ||||
Northeast | 22,517 (47.7) | 552,404 (19.5) | 22,118 (46.9) | 0.02 |
South | 11,832 (25.1) | 1,085,094 (38.3) | 12,253 (26.0) | −0.02 |
Midwest | 7,044 (14.9) | 695,434 (24.5) | 7,106 (15.1) | 0.00 |
West | 5,801 (12.3) | 501,593 (17.7) | 5,717 (12.1) | 0.00 |
Health status | ||||
Elixhauser comorbidity count = 0, N (%) | 11,962 (25.4) | 780,034 (27.5) | 12,637 (26.8) | −0.03 |
Elixhauser comorbidity count = 1–2, N (%) | 21,211 (44.9) | 1,174,156 (41.4) | 21,977 (46.6) | −0.03 |
Elixhauser comorbidity count ≥3, N (%) | 14,021 (29.7) | 880,335 (31.1) | 12,580 (26.7) | 0.07 |
Overall Elixhauser comorbidity count, mean (std) | 1.98 (2.1) | 2.00 (2.1) | 1.79 (1.8) | 0.05 |
Comorbidity count if Elixhauser count ≥3 mean (std) | 4.51 (1.9) | 4.52 (1.8) | 4.22 (1.6) | 0.09 |
Demographic and health status data before and after propensity score matching are displayed above.
Standardized difference after propensity score matching is calculated as the standardized difference of means between the two groups. Absolute values greater than or equal to 0.10 were interpreted as a statistically significant difference between the two cohorts.
Median income is derived from patient zip code, not individual level data.
NHS, Nurses' Health Study.